Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Blood
|
September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion
Claudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Cell Reports
|
August 24, 2022
Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
Salvatore Cortellino, Alessandro Raveane, Claudia Chiodoni, et al.
Nature Communications
|
July 7, 2016
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, et al.
Frontiers in Immunology
|
January 10, 2018
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
Mariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2014
CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin
Clara Guerzoni, Valentina Fiori, Mario Terracciano, et al.
Cancer Research
|
February 20, 2019
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
Cristina Travelli, Francesca Maria Consonni, Sabina Sangaletti, et al.
Blood Advances
|
June 13, 2022
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
Celia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, et al.
Cancer Immunology Research
|
May 4, 2021
T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
Gaia Morello, Valeria Cancila, Massimo La Rosa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2025
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
Lorenzo Castagnoli, Alma Franceschini, Valeria Cancila, et al.
Cancer Immunology Research
|
June 13, 2024
Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer
Roberta Sulsenti, Giuseppina B Scialpi, Barbara Frossi, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Blood
|
September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion
Claudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Cell Reports
|
August 24, 2022
Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
Salvatore Cortellino, Alessandro Raveane, Claudia Chiodoni, et al.
Nature Communications
|
July 7, 2016
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, et al.
Frontiers in Immunology
|
January 10, 2018
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
Mariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2014
CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin
Clara Guerzoni, Valentina Fiori, Mario Terracciano, et al.
Cancer Research
|
February 20, 2019
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
Cristina Travelli, Francesca Maria Consonni, Sabina Sangaletti, et al.
Blood Advances
|
June 13, 2022
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
Celia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, et al.
Cancer Immunology Research
|
May 4, 2021
T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
Gaia Morello, Valeria Cancila, Massimo La Rosa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2025
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
Lorenzo Castagnoli, Alma Franceschini, Valeria Cancila, et al.
Cancer Immunology Research
|
June 13, 2024
Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer
Roberta Sulsenti, Giuseppina B Scialpi, Barbara Frossi, et al.
Page
of 15